A first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06741086, an anti-tissue factor pathway inhibitor mAb, in healthy volunteers - Cardinal, M; Kantaridis, C; Zhu, T (J Thromb Haemost, 2018)